Anaphylactic Shock News and Research

RSS
Anaphylactic shock or anaphylaxis is a severe and sometimes life-threatening immune system reaction to an antigen that a person has been previously exposed to. The reaction may include itchy skin, edema, collapsed blood vessels, fainting, difficulty in breathing, and death.
Tyson Foods Inc. recalls over 2 million pounds of chicken products

Tyson Foods Inc. recalls over 2 million pounds of chicken products

Citric acid in e-liquids may produce significant amounts of respiratory sensitisers in e-cigarette vapour

Citric acid in e-liquids may produce significant amounts of respiratory sensitisers in e-cigarette vapour

Bees pose biggest public health threat in Australia, research shows

Bees pose biggest public health threat in Australia, research shows

Enzyme identified in baker's yeast can efficiently annihilate leukemia cells

Enzyme identified in baker's yeast can efficiently annihilate leukemia cells

Researchers develop new way to test strength of immune response

Researchers develop new way to test strength of immune response

Researchers discover new therapeutic target for controlling fatal allergic reactions

Researchers discover new therapeutic target for controlling fatal allergic reactions

New drug holds potential for treating advanced mastocytosis

New drug holds potential for treating advanced mastocytosis

Specific commercial red algae could help combat food allergies

Specific commercial red algae could help combat food allergies

Breakthrough technique removes potentially harmful additives from common injectable drugs

Breakthrough technique removes potentially harmful additives from common injectable drugs

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Hypersexual disorder can be linked to hyperactive stress systems

Hypersexual disorder can be linked to hyperactive stress systems

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

New cell type appears to drive life-threatening food allergies

New cell type appears to drive life-threatening food allergies

New research reveals why some kids can have severe allergic reaction hours later

New research reveals why some kids can have severe allergic reaction hours later

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

EpiPen (epinephrine) emergency kits now available at Montreal Bell Centre for treating severe allergies

EpiPen (epinephrine) emergency kits now available at Montreal Bell Centre for treating severe allergies

UConn chemists develop more advanced peanut allergy test

UConn chemists develop more advanced peanut allergy test

FDA approves Contrave extended-release tablets for chronic weight management

FDA approves Contrave extended-release tablets for chronic weight management

New ingredient in gluten-free products can cause allergic reaction

New ingredient in gluten-free products can cause allergic reaction